RadioMedix

NEWS

Image of Houston downtown park and skyline in the morning

Business

Houston’s Life Sciences Scene Continues Boosting Its Reputation

While Houston isn’t yet on the same level as major life sciences hubs, it has plenty to offer and room to grow, according to CNS Pharmaceuticals, RadioMedix and Greater Houston Partnership executives.

March 13, 2025

6 min read

Angela Gabriel

IN THE PRESS

Business

Extended Partnership Between RadioMedix And ITM´s Subsidiary ITG For Exclusive Distribution Of N.C.A Lutetium-177 In North America

October 11, 2017

4 min read

Lone Star Bio

RadioMedix Release: First U.S. Multi-Center Investigational Clinical Trial Of 177 Lu PSMA-617 Targeted Radioligand Therapy In Metastatic Castration Resistant Prostate Cancer Receives FDA Clearance

February 6, 2017

4 min read

Lone Star Bio

RadioMedix And AREVA Med – SBIR NCI Contract Grant Awarded To Develop Targeted Alpha-Emitter Therapy Of Neuroendocrine Tumors With Lead-212

November 1, 2016

3 min read

Drug Development

RadioMedix Successfully Completed The Phase I/ II Clinical Studies For Aminomedix Used For Radiation Kidney Protection During Peptide-Receptor Radionuclide Therapy (PRRT)

October 20, 2016

2 min read

Lone Star Bio

Radiomedix Successful Installations Of Smartmedix And All In One (AIO) Fully Automated Radiosynthesizers In USA.

September 12, 2016

3 min read

Business

AREVA Med LLC And Radiomedix Partner To Develop New Treatment Against Neuroendocrine Tumors

May 18, 2015

3 min read

JOBS